hematologic disease: A disease involving the hematopoietic system.
Other and unspecified diseases of blood and blood-forming organs
DOID EFO Endpoint Browser PheWeb
D3_BLOODNAS
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
890 |
4. Check minimum number of eventsNone |
890 |
5. Include endpointsNone |
890 |
6. Filter based on genotype QC (FinnGen only) |
890 |
Control definitions (FinnGen only)
- Control exclude
- D3_BLOODOTHER
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Other and unspecified diseases of blood and blood-forming organs
based on the number of shared cases.
Similar with more cases:
- Other diseases of blood and blood-forming organs
- Other diseases of blood and blood-forming organs, wide
- Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 6321 | 3318 | 2939 |
| Only index persons | 5103 | 2725 | 2378 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.09 | 0.10 | 0.08 |
| Only index persons | 0.10 | 0.10 | 0.09 |
| Median age at first event (years) | |||
| Whole population | 59.07 | 58.15 | 60.11 |
| Only index persons | 57.37 | 55.93 | 59.01 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 890 | 480 | 410 |
| Unadjusted period prevalence (%) | 0.17 | 0.16 | 0.18 |
| Median age at first event (years) | 58.87 | 56.64 | 61.48 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 806
- Matched controls
- 8060
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D75.9
ICD-10 Finland
Disease of blood and blood-forming organs, unspecified
10423.5
323.0
644
*
XW000
NOMESCO Finland
Bone marrow biopsy
49.2
258.1
314
103
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
29.2
171.3
237
113
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
93.2
150.3
164
22
L01XX05
ATC
hydroxycarbamide; oral
87.2
125.2
138
19
D47.3
ICD-10 Finland
Essential (haemorrhagic) thrombocythaemia
130.1
124.3
131
12
D75.8
ICD-10 Finland
Other specified diseases of blood and blood-forming organs
+∞
104.5
98
*
D75.2
ICD-10 Finland
Essential thrombocytosis
284.8
100.2
100
*
D45
ICD-10 Finland
Polycythaemia vera
51.8
73.5
88
19
9962/3-C42.1
ICD-O-3
Essential thrombocythemia of bone marrow
144.4
51.5
54
*
D75.1
ICD-10 Finland
Secondary polycythaemia
+∞
46.3
44
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.2
45.8
197
570
TPH00
NOMESCO Finland
Phlebotomy
59.4
38.7
45
8
28998
ICD-8 Finland
Other disease of blood and blood-forming organs, Alii definiti
+∞
34.6
33
*
D47.1
ICD-10 Finland
Chronic myeloproliferative disease
75.1
32.1
36
5
SPAT1074
SPAT
Venesection
62.7
31.3
36
6
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.4
29.5
416
2511
WW500
NOMESCO Finland
Blood transfusion
7.4
28.7
70
102
28999
ICD-8 Finland
Other disease of blood and blood-forming organs, Other and unspecified
+∞
28.3
27
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.7
25.1
120
367
Z2221
NOMESCO Finland
Medical doctor
2.3
24.1
279
1484
D64.9
ICD-10 Finland
Anaemia, unspecified
3.3
22.1
121
409
D75.0
ICD-10 Finland
Familial erythrocytosis
+∞
22.0
21
*
9950/3-C42.1
ICD-O-3
Polycythemia vera of bone marrow
64.4
22.0
25
*
9960/3-C42.1
ICD-O-3
Myeloproliferative neoplasm, NOS, of bone marrow
225.8
21.7
22
*
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
49.4
20.2
24
5
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
59.1
20.0
23
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.2
19.8
266
1492
ZXE00
NOMESCO Finland
One hour or less
1.9
16.8
334
2159
D70.89
ICD-10 Finland
Neutropenic splenomegaly
64.7
16.8
19
*
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
8.3
15.9
35
44
TPH04
NOMESCO Finland
Cathetrisation of vein
2.2
15.8
196
1046
XF400
NOMESCO Finland
ECG with 12 standard connections
2.3
15.2
165
825
D46.7
ICD-10 Finland
Other myelodysplastic syndromes
32.4
14.9
19
6
C92.1
ICD-10 Finland
Chronic myeloid leukaemia [CML], BCR/ABL-positive
32.4
14.9
19
6
L03AB05
ATC
interferon alfa-2b; parenteral
22.7
14.3
20
9
ZX120
NOMESCO Finland
Intravenous
2.7
14.2
102
410
C90.0
ICD-10 Finland
Multiple myeloma
9.3
13.3
27
30
189
Kela drug reimbursment
Imatinib
50.8
12.9
15
*
R4110
NOMESCO Finland
Physiotherapy
1.9
12.5
229
1404
WW200
NOMESCO Finland
Immunization
5.1
12.5
39
80
M04AA01
ATC
allopurinol; systemic
2.3
12.3
122
582
ZXE10
NOMESCO Finland
More than one and less than three hours
1.8
12.1
301
2034
9732/3-C42.1
ICD-O-3
Plasma cell myeloma of bone marrow
11.3
12.1
22
20
L03AA02
ATC
filgrastim; parenteral
5.4
11.6
34
65
2898X
ICD-9 Finland
Other diseases of blood and blood-forming organs, Other specified diseases of blood and blood-forming organs
+∞
11.5
11
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.4
11.5
105
481
WX002
NOMESCO Finland
Sedation and analgesia
2.0
11.5
174
991
H02AB06
ATC
prednisolone; systemic
1.7
11.4
378
2772
C03CA01
ATC
furosemide; systemic
1.8
11.4
240
1534
R79.9
ICD-10 Finland
Abnormal finding of blood chemistry, unspecified
15.3
11.3
18
12
WX892
NOMESCO Finland
Monitored bed care
2.7
11.0
76
298
L01XX35
ATC
anagrelide; oral
43.9
10.9
13
*
Z3226
NOMESCO Finland
Physiotherapist
2.0
10.8
162
918
D47.2
ICD-10 Finland
Monoclonal gammopathy of undetermined significance (MGUS)
6.9
10.4
25
37
122
Kela drug reimbursment
Aplastic anaemia
+∞
10.4
10
*
374
Kela drug reimbursment
Ruxolitinib
+∞
10.4
10
*
L01EJ01
ATC
ruxolitinib; oral
+∞
10.4
10
*
174
Kela drug reimbursment
Ruxolitinib
+∞
10.4
10
*
R11
ICD-10 Finland
Nausea and vomiting
2.7
10.4
73
290
Z01.8
ICD-10 Finland
Other specified special examinations
1.9
10.1
180
1083
R50.9
ICD-10 Finland
Fever, unspecified
2.1
10.0
122
636
WX402
NOMESCO Finland
General anaesthesia
2.0
9.9
134
729
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.6
9.7
71
286
Z3231
NOMESCO Finland
Registered nurse
1.7
9.7
225
1471
L01XE01
ATC
[U] imatinib; oral
55.7
9.7
11
*
L01EA01
ATC
imatinib; oral (bcr-abl tyrosine kinase inhibitors)
55.7
9.7
11
*
D72.9
ICD-10 Finland
Disorder of white blood cells, unspecified
101.2
9.4
10
*
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
17.8
9.4
14
8
L04AD01
ATC
ciclosporin; systemic
5.7
9.4
26
47
L01XE18
ATC
[U] ruxolitinib; oral
+∞
9.4
9
*
2899X
ICD-9 Finland
Other diseases of blood and blood-forming organs, Unspecified diseases of blood and blood-forming organs
+∞
9.4
9
*
ZXD10
NOMESCO Finland
Scheduled procedure
1.6
9.3
306
2200
ZXD05
NOMESCO Finland
Urgent procedure
1.7
9.3
243
1643
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.8
9.3
59
222
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.4
9.2
80
355
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.9
9.2
150
870
WX408
NOMESCO Finland
General anesthesy, balanced
1.7
9.2
210
1366
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.7
9.1
260
1797
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
3.1
9.1
49
166
9961/3-C42.1
ICD-O-3
Primary myelofibrosis of bone marrow
37.1
9.0
11
*
L03AB04
ATC
interferon alfa-2a; parenteral
37.1
9.0
11
*
D47.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified
24.3
8.9
12
5
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
8.7
8.8
18
21
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.8
8.8
56
211
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.2
8.6
84
399
UJF92
NOMESCO Finland
Capsular endoscopy
4.8
8.5
27
58
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
2.2
8.5
90
443
TPH07
NOMESCO Finland
Cathetrisation of artery
2.1
8.3
91
454
UJF32
NOMESCO Finland
Coloscopy
1.7
8.3
199
1304
J01MA12
ATC
levofloxacin; systemic
1.8
8.2
147
878
XF600
NOMESCO Finland
Bloodpressure measurement
2.6
8.2
60
246
C07AB07
ATC
bisoprolol; oral
1.5
8.2
366
2816
UJF30
NOMESCO Finland
Ileoscopy through colon
2.2
8.1
78
368
R72
ICD-10 Finland
Abnormality of white blood cells, not elsewhere classified
22.3
8.0
11
5
B01AB05
ATC
enoxaparin; parenteral
1.6
8.0
240
1672
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.3
7.9
70
316
B99
ICPC
Blood/lymph/spleen disease other
10.9
7.8
14
13
316
Kela drug reimbursment
Imatinib
45.4
7.7
9
*
JN4BD
NOMESCO Finland
Extensive body CT
2.0
7.5
91
472
A02BC02
ATC
pantoprazole; systemic
1.5
7.5
492
4099
C03DA01
ATC
spironolactone; oral
2.1
7.5
89
459
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.8
7.4
129
762
D73.0
ICD-10 Finland
Hyposplenism
+∞
7.3
7
*
ZXA10
NOMESCO Finland
Bilateral
1.7
7.2
145
899
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.7
7.2
157
998
N02AX02
ATC
tramadol; systemic, rectal
1.5
7.2
320
2439
D59.1
ICD-10 Finland
Other autoimmune haemolytic anaemias
30.3
7.2
9
*
9861/3-C42.1
ICD-O-3
Acute myeloid leukemia, NOS, of bone marrow
30.3
7.2
9
*
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
2.8
7.1
45
167
R53
ICD-10 Finland
Malaise and fatigue
1.7
7.1
147
917
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
12.2
7.1
12
10
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.6
7.1
227
1600
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
2.3
7.1
62
280
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.5
7.1
53
221
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
3.6
6.8
29
83
ZX108
NOMESCO Finland
Inhalation
11.0
6.8
12
11
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.3
6.8
60
273
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
2.0
6.8
80
412
R06.0
ICD-10 Finland
Dyspnoea
1.6
6.8
193
1321
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
12.4
6.6
11
9
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.8
6.5
124
755
TK800
NOMESCO Finland
Hemodialysis
4.3
6.5
22
52
9863/3-C42.1
ICD-O-3
Chronic myeloid leukemia, NOS, of bone marrow
70.4
6.4
7
*
6BA02
NOMESCO Finland
NA
70.4
6.4
7
*
127
Kela drug reimbursment
Transplant complication
5.0
6.4
19
39
D64.8
ICD-10 Finland
Other specified anaemias
5.2
6.3
18
35
D46.9
ICD-10 Finland
Myelodysplastic syndrome, unspecified
9.3
6.3
12
13
D70.82
ICD-10 Finland
Drug-induced neutropenia
+∞
6.3
6
*
TNE20
NOMESCO Finland
Bone marrow aspiration, pelvis
26.9
6.2
8
*
B03XA02
ATC
darbepoetin alfa; parenteral
4.5
6.2
20
45
M79.6
ICD-10 Finland
Pain in limb
1.5
6.2
254
1889
E86
ICD-10 Finland
Volume depletion
3.9
6.1
23
60
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.5
6.1
336
2653
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
2.1
6.1
64
314
B01AB10
ATC
tinzaparin; parenteral
2.2
6.0
55
255
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3042111) Morphology [Interpretation] in Bone marrow Narrative
272
94
41.23
307.65
1.8
1.7
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
247
58
58.56
307.65
1.3
1.3
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
462
775
11.32
297.87
8.2
3.7
u/l
257.0
247.5
0.34
454
737
(21494434) Karyotype in Bone marrow
178
56
39.48
282.42
1.2
1.1
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
202
112
23.04
260.24
1.5
1.2
u/l
47.0
33.0
0.40
178
102
(3027945) Reticulocytes/100 erythrocytes in Blood
421
796
9.14
238.34
4.1
2.4
%
1.9
1.8
0.28
389
719
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
173
83
25.63
236.31
1.0
1.0
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
354
582
9.44
225.22
4.4
2.5
e9/l
78.2
71.2
1.85
237
451
(42870588) Differential panel, method unspecified - Blood
635
2386
6.80
164.44
13.8
5.5
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
686
3269
5.79
119.89
14.5
5.6
%
0.8
0.7
6.00
661
3049
(3006504) Eosinophils/100 leukocytes in Blood
692
3361
5.76
116.91
14.6
5.6
%
2.8
2.9
0.31
666
3127
(3019069) Monocytes/100 leukocytes in Blood
693
3381
5.74
116.09
15.1
5.9
%
9.3
8.7
2.42
668
3167
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
344
984
5.07
115.06
3.5
2.4
%
24.6
22.4
1.57
310
841
(3002030) Lymphocytes/100 leukocytes in Blood
694
3459
5.57
111.14
14.9
5.7
%
28.4
27.6
0.92
667
3224
(3018010) Neutrophils/100 leukocytes in Blood
683
3417
5.29
107.25
14.2
5.5
%
56.4
57.4
1.33
653
3198
(3004789) Transferrin [Mass/volume] in Serum or Plasma
345
1046
4.75
106.12
3.4
2.4
g/l
2.3
2.3
0.16
330
972
(3006315) Basophils [#/volume] in Blood
692
3599
5.15
100.46
13.6
5.5
e9/l
0.1
0.0
11.14
612
3112
(3001604) Monocytes [#/volume] in Blood
689
3583
5.09
99.73
13.6
5.5
e9/l
0.7
0.6
2.92
610
3093
(3013115) Eosinophils [#/volume] in Blood
701
3715
5.18
98.36
15.2
5.8
e9/l
0.2
0.2
1.18
638
3267
(3022948) Iron [Moles/volume] in Serum or Plasma
352
1141
4.45
98.10
3.5
2.4
umol/l
13.7
12.7
1.31
338
1053
(3019198) Lymphocytes [#/volume] in Blood
694
3674
5.04
96.85
13.9
5.6
e9/l
2.3
1.9
1.10
629
3239
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
166
314
6.27
86.88
3.0
1.8
g/l
1.2
1.5
3.23
149
275
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
138
216
7.38
86.81
5.5
2.7
g/l
0.1
0.0
0.24
130
204
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
143
238
6.97
84.88
5.4
3.0
g/l
1.8
1.1
0.83
132
218
(3013650) Neutrophils [#/volume] in Blood by Automated count
722
4184
4.84
82.87
21.7
8.5
e9/l
4.6
4.1
2.77
651
3658
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
87
81
11.80
82.12
2.9
2.1
pg
32.7
33.2
0.34
87
81
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
130
204
7.29
81.43
5.3
2.7
g/l
0.0
0.0
0.00
122
192
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
127
202
7.17
78.48
5.4
2.7
g/l
0.0
0.0
0.00
122
191
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
145
265
6.34
78.28
5.4
2.6
g/l
3.1
3.2
0.01
124
216
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
132
228
6.62
75.29
5.2
2.6
g/l
37.9
37.5
0.29
123
202
(3021589) Normoblasts [#/volume] in Blood
595
3159
3.67
74.16
20.6
9.1
e9/l
0.0
0.0
1.25
488
2581
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
146
285
5.93
73.44
5.4
2.6
g/l
3.8
3.8
0.02
124
213
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
146
285
5.93
73.44
5.4
2.6
g/l
7.0
7.4
1.45
124
223
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
146
285
5.93
73.44
5.4
2.6
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
138
263
6.03
71.11
5.2
2.6
g/l
10.9
10.5
0.32
124
234
(3034860) Kappa light chains.free [Mass/volume] in Serum
125
225
6.30
68.22
5.9
3.9
mg/l
54.5
82.8
0.46
111
184
(3026493) Urate [Moles/volume] in Serum or Plasma
425
1907
3.35
68.13
4.6
2.6
umol/l
2415.4
7774.4
2.17
392
1649
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
125
226
6.27
67.90
5.9
3.9
mg/l
41.4
42.7
0.03
111
186
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
119
205
6.55
67.84
3.2
2.2
%
90.4
89.9
0.07
111
194
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
123
221
6.30
67.22
5.9
3.8
ratio
11.8
1.9
—
7
24
(3004588) Protein electrophoresis panel - Serum or Plasma
191
507
4.52
66.76
4.5
2.7
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
208
601
4.21
64.86
4.4
3.0
g/l
66.8
66.7
0.04
194
553
(40758558) Short blood count panel - Blood
400
1799
3.22
62.71
15.6
6.3
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
191
546
4.18
60.12
3.3
2.8
g/l
10.8
10.9
0.02
176
497
(3033658) Prothrombin time (PT) actual/Normal
394
1802
3.13
59.28
8.4
3.8
%
86.8
90.8
2.19
380
1761
(3000093) Morphology [Interpretation] in Blood Narrative
60
56
11.42
56.24
1.2
1.1
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
162
430
4.38
56.08
2.5
1.7
g/l
1.6
1.5
0.06
151
393
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
629
3824
3.20
55.45
11.1
6.0
umol/l
11.2
11.3
0.16
614
3639
(3018418) pH of Serum or Plasma
435
2165
2.97
55.32
7.9
4.0
ph
7.4
7.4
0.58
86
399
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
49
37
13.96
52.30
1.7
1.4
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
49
37
13.96
52.30
1.7
1.4
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
381
1819
2.91
51.47
3.0
2.1
mg/l
3.5
3.0
1.22
326
1543
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
94
168
6.14
51.31
1.6
1.6
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
92
162
6.22
50.98
1.8
1.7
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
93
166
6.14
50.83
4.4
4.2
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
187
590
3.75
50.59
7.0
4.3
%
0.9
0.8
0.09
71
178
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
554
3311
2.78
47.16
9.7
6.0
mmol/l
1.2
1.2
0.69
522
2998
(3025159) Blasts/100 leukocytes in Blood
170
532
3.71
46.29
7.0
4.4
%
0.4
0.7
0.20
62
141
(3001122) Ferritin [Mass/volume] in Serum or Plasma
523
3055
2.73
46.28
5.1
2.7
ug/l
176.7
133.9
0.95
492
2810
(3002179) Metamyelocytes/100 leukocytes in Blood
172
543
3.69
46.22
6.3
4.0
%
0.7
0.4
0.73
59
137
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
218
815
3.22
44.69
6.0
2.7
umol/l
6.2
8.2
1.94
194
715
(3024561) Albumin [Mass/volume] in Serum or Plasma
529
3151
2.67
44.28
8.4
4.7
g/l
35.3
35.5
0.35
501
2942
(3003458) Phosphate [Moles/volume] in Serum or Plasma
243
977
3.05
43.85
7.7
5.5
mmol/l
1.1
1.0
0.69
233
897
(3021440) Promyelocytes/100 leukocytes in Blood
171
566
3.50
42.54
6.8
4.4
%
0.1
0.1
0.28
68
166
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
31
14
22.91
42.15
1.1
1.5
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
576
3644
2.65
41.52
10.8
6.8
mmol/l
1.2
1.2
0.07
475
3096
(36304419) Bacteria [Presence] in Urine
368
1931
2.54
38.74
4.2
3.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
88
194
4.92
37.93
1.3
1.3
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
146
480
3.44
36.40
1.4
1.4
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
71
138
5.50
35.27
4.9
3.5
%
58.2
58.7
0.10
71
138
(3030467) Casts [#/volume] in Urine by Automated count
368
2004
2.43
34.91
4.2
3.2
e6/l
0.7
0.5
0.63
292
1526
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
62
107
6.15
34.87
1.4
1.4
u/ml
83.4
108.1
—
8
19
(3002582) Erythrocytes [#/volume] in Urine
390
2192
2.39
34.30
4.3
3.3
e6/l
49.1
88.7
0.58
309
1710
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
748
5644
3.04
33.99
16.3
7.3
u/l
81.4
78.3
1.26
724
5290
(3018677) aPTT in Platelet poor plasma by Coagulation assay
248
1136
2.64
33.93
3.7
2.0
s
30.3
29.7
0.84
239
1099
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
64
119
5.72
33.32
1.4
1.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
186
744
2.90
33.00
1.7
1.5
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
67
134
5.33
32.22
3.7
3.2
e9/l
5.0
4.5
0.58
67
134
(3047189) Immunofixation for 24 hour Urine
35
34
10.67
31.73
2.2
1.6
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
425
2547
2.28
31.40
5.3
3.8
e6/l
58.4
103.7
1.20
321
1831
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
203
888
2.67
30.10
1.7
1.5
—
—
—
0
0
(3026782) Osmolality of Urine
274
1404
2.37
28.80
3.6
2.8
mosm/kgh2o
530.1
547.4
0.65
236
1202
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
425
2621
2.19
28.43
4.1
3.3
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
208
945
2.57
28.39
1.4
1.3
titre
355.8
469.1
0.64
38
209
(21494890) Protein electrophoresis panel - 24 hour Urine
47
76
6.47
28.13
2.5
2.1
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
241
1178
2.43
28.07
3.6
3.0
e6/l
1.9
2.4
0.54
143
669
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
36
43
8.68
28.04
1.2
1.3
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
162
656
2.80
27.76
2.8
2.3
u/l
35.3
33.9
0.12
143
550
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
469
3026
2.16
27.72
2.6
2.0
pmol/l
88.2
94.9
2.75
293
1541
(3012095) Magnesium [Moles/volume] in Serum or Plasma
241
1186
2.42
27.59
4.7
3.3
mmol/l
0.8
0.8
0.01
232
1111
(40760892) CBC W Ordered Manual Differential panel - Blood
288
1533
2.30
27.51
8.6
4.7
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
391
2357
2.18
27.45
5.6
3.2
u/l
34.1
33.0
0.19
379
2249
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
268
1388
2.33
27.26
4.8
4.0
ng/l
104.4
351.6
2.71
221
1090
(4035726)
156
638
2.75
26.13
1.6
1.4
—
—
—
0
0
(3000012) Reticulocyte production index
30
31
9.98
26.00
1.5
2.1
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
261
1373
2.27
25.32
2.2
1.4
g/l
2.5
2.5
0.09
182
831
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
60
136
4.66
24.89
6.1
6.1
iu/ml
1046.2
132.4
—
9
14
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
30
7
44.23
24.70
1.1
1.1
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
216
1066
2.36
24.21
1.8
1.8
—
—
—
0
0
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
23
0
+∞
24.07
8.2
0.0
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
258
1377
2.23
23.98
2.0
1.7
nmol/l
1103.8
1173.1
0.50
199
1039
(3021960) Folate [Moles/volume] in Serum or Plasma
306
1755
2.13
23.65
2.0
1.5
nmol/l
20.8
20.8
0.00
286
1482
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
101
342
3.20
23.64
5.9
4.0
mmol/l
23.7
24.3
0.96
96
307
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
284
1583
2.17
23.62
2.5
1.6
mg/l
1.5
1.1
1.09
238
1220
(40761536) Microorganisms panel - Urine sediment
143
588
2.71
23.57
4.7
3.8
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
694
5412
2.28
23.01
5.6
4.1
mm/h
16.2
12.4
5.47
653
4976
(3000850) Epithelial cells [#/volume] in Urine
271
1501
2.16
22.77
3.3
2.6
e6/l
3.9
5.2
1.95
235
1322
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
55
128
4.51
22.07
1.3
1.2
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
23
21
11.22
21.62
1.5
3.0
%
146.1
124.2
0.49
23
21
(3052851) Hemolysis interference index of Serum or Plasma
72
210
3.64
21.27
3.8
3.2
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
32
47
7.03
20.91
1.8
1.8
e6/l
1051.7
759.0
—
6
16
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
52
122
4.46
20.65
1.3
1.2
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
576
4275
1.98
20.50
8.8
4.8
mmol/l
6.7
6.7
0.07
554
4020
(3004809) Band form neutrophils/100 leukocytes in Blood
49
112
4.57
20.10
6.3
3.1
%
1.2
1.2
0.02
36
96
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
28
37
7.78
20.04
2.1
2.1
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
144
641
2.49
20.01
10.7
7.3
mmol/l
10.0
9.7
0.19
138
607
(3000991) Gas panel - Venous blood
137
600
2.52
19.69
11.5
9.0
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
245
1371
2.09
19.62
3.6
3.0
mmol/l
2.5
2.4
0.34
218
1198
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
34
58
6.06
19.28
1.1
1.2
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
23
5
47.12
19.27
1.1
1.0
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
227
1248
2.10
18.97
3.4
2.8
e6/l
0.8
1.2
1.50
131
738
(3017817) Protein [Mass] in Urine collected for unspecified duration
35
63
5.74
18.80
2.1
2.2
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
19
16
12.11
18.74
2.2
2.1
e6/l
1520.7
296.0
—
14
5
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
35
64
5.65
18.49
2.2
2.4
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
31
51
6.26
18.21
2.1
2.0
e9/l
1.4
1.1
0.47
20
28
(3015377) Calcium [Moles/volume] in Serum or Plasma
374
2480
1.88
17.95
4.1
3.3
mmol/l
2.3
2.4
1.15
337
2150
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
49
124
4.12
17.65
1.4
1.2
u/ml
237.4
270.9
0.31
34
71
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
27
40
6.93
17.49
2.0
2.2
e6/l
680.0
540.7
0.43
22
32
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
26
37
7.21
17.45
2.1
2.0
%
13.5
12.6
0.11
20
20
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
46
112
4.28
17.43
1.2
1.1
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
634
4991
1.94
17.42
5.5
4.3
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
35
68
5.32
17.33
1.1
1.1
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
67
215
3.29
17.06
2.3
1.6
g/l
0.2
0.2
0.23
61
206
(3048929) Epstein Barr virus Ab [Presence] in Serum
62
190
3.43
16.97
1.3
1.2
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
427
2993
1.82
16.81
12.8
9.0
inr
1.2
1.2
0.13
149
852
(3007853) Bacteria identified in Skin by Aerobe culture
167
855
2.17
16.58
2.2
1.7
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
33
64
5.32
16.37
1.1
1.1
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
70
238
3.11
16.20
4.3
2.8
u/ml
0.3
0.4
0.30
41
130
(3002385) Erythrocyte distribution width [Ratio]
719
5971
2.06
16.12
42.6
17.4
%
14.8
13.7
29.31
711
5852
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
50
138
3.78
15.99
1.6
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
50
138
3.78
15.99
1.6
1.3
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
67
224
3.15
15.95
2.3
1.6
g/l
1.2
1.2
0.78
62
213
(3044889) 12 lead EKG panel
640
5123
1.89
15.83
4.7
3.9
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
117
526
2.41
15.76
2.2
1.5
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
158
817
2.14
15.21
2.2
1.8
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
332
2207
1.80
15.17
2.5
2.1
u/l
165.4
231.3
0.94
312
2088
(3009261) Glucose [Presence] in Urine by Test strip
481
3564
1.76
15.09
3.8
3.7
estimate
0.0
0.0
0.50
127
628
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
158
822
2.12
14.95
2.2
1.8
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
142
709
2.19
14.92
3.1
2.2
g/l
0.2
0.2
0.20
129
664
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
203
1165
1.96
14.63
2.3
1.8
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
474
3523
1.74
14.48
5.3
5.1
estimate
0.0
0.0
0.50
133
649
(3023368) Bacteria identified in Blood by Culture
304
1992
1.80
14.43
7.1
4.1
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
28
53
5.42
14.26
1.2
1.2
titre
270.0
85.5
—
6
11
(3044640) Blood type and Crossmatch panel - Blood
340
2310
1.76
14.21
5.4
2.3
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
471
3509
1.73
14.14
3.7
3.7
estimate
0.0
0.0
0.00
128
645
(3016650) Hepatitis A virus Ab [Presence] in Serum
45
126
3.71
14.11
1.2
1.1
—
—
—
0
0
(3024471) HLA-A [Type]
16
17
9.57
13.47
1.0
1.0
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
16
17
9.57
13.47
1.3
1.1
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
68
257
2.78
13.02
1.6
1.7
—
197.5
—
0
8
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
14
13
10.93
12.88
1.0
1.0
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
13
11
11.98
12.66
1.1
1.4
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
13
11
11.98
12.66
1.2
1.1
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
811
7226
2.38
12.62
30.1
14.2
mg/l
21.6
24.0
1.50
714
5733
(1616796) Gas panel - Central venous blood
46
143
3.34
12.33
5.6
3.5
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
17
22
7.86
12.32
1.3
1.1
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
143
773
2.01
12.06
4.3
3.2
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
17
8
21.63
12.04
1.1
1.3
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
22
39
5.76
11.99
1.6
1.1
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
17
23
7.52
11.87
1.4
1.6
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
36
98
3.79
11.76
1.4
1.2
u/ml
1.4
2.5
0.69
15
28
(3036603) Volume of Urine
25
51
5.01
11.74
1.9
1.5
—
1911.0
—
0
12
(3042936) Bacteria identified in Isolate by Culture
179
1054
1.87
11.71
2.5
2.1
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
14
15
9.47
11.68
1.0
1.0
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
289
1969
1.69
11.42
1.8
1.7
mmol/l
1.5
1.4
1.88
226
1658
(3048879) Bone marrow aspiration report
14
16
8.87
11.14
1.1
2.4
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
263
1757
1.71
11.14
5.5
2.3
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
402
2997
1.62
11.07
3.0
2.3
nmol/l
78.1
77.0
0.32
365
2665
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
36
103
3.60
10.96
1.4
1.2
u/ml
4.9
6.0
0.14
19
39
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
84
383
2.32
10.89
11.5
12.1
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
16
9
18.07
10.75
1.4
1.1
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
173
1035
1.83
10.68
1.3
1.2
—
—
—
0
0
(3024932) HLA-DR beta [Type]
14
17
8.35
10.63
1.2
1.1
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
14
17
8.35
10.63
1.0
1.0
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
12
12
10.12
10.46
1.1
1.1
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
114
599
2.04
10.35
3.2
2.9
ng/l
232.3
207.1
0.26
104
551
(3002032) Base excess in Venous blood by calculation
124
677
1.97
10.10
5.9
3.7
mmol/l
1.0
2.0
1.56
101
545
(3021447) Carbon dioxide [Partial pressure] in Venous blood
124
687
1.94
9.66
5.9
3.6
kpa
5.9
5.8
0.31
117
668
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
111
594
1.99
9.56
5.3
3.7
mmol/l
1.2
1.2
0.05
90
516
(3041096) Erythrocytes [Presence] in Urine by Automated
273
1906
1.62
9.49
3.8
3.4
—
—
—
0
0
(3012501) Base excess in Blood by calculation
41
141
3.00
9.34
7.0
3.7
mmol/l
2.7
2.6
0.04
29
96
(3036481) Cortisol [Moles/volume] in Serum or Plasma
119
661
1.92
9.19
2.4
2.0
nmol/l
330.1
378.4
2.11
113
605
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
25
63
4.05
9.10
1.2
1.2
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
15
24
6.34
9.01
1.1
1.1
—
14.8
—
0
5
(3010421) pH of Blood
47
178
2.73
9.00
6.7
3.6
ph
7.4
7.4
0.11
40
138
(40768804) Tissue Pathology biopsy report
380
2896
1.54
8.94
2.4
2.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
36
925
0.36
8.73
7.9
7.3
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
31
94
3.38
8.68
1.2
1.1
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
19
40
4.83
8.62
2.6
1.2
ug/l
11.4
5.9
1.14
19
34
(3009542) Hematocrit [Volume Fraction] of Blood
736
6540
1.72
8.59
38.8
15.3
%
39.2
39.8
0.87
536
4585
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
566
4726
1.54
8.58
4.7
3.1
u/l
59.9
49.1
1.53
543
4405
(3003396) Base excess in Arterial blood by calculation
142
853
1.79
8.54
8.9
8.3
mmol/l
0.4
1.3
1.59
124
668
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
51
207
2.55
8.53
1.9
1.6
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
16
29
5.60
8.52
1.2
1.6
mg/l
57.5
74.3
0.51
11
21
(4268621)
25
68
3.75
8.22
2.6
2.3
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
427
3390
1.50
8.00
7.8
4.0
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
84
443
1.99
7.53
2.1
1.7
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
736
6609
1.66
7.43
5.5
4.7
mu/l
1.9
2.1
0.47
679
6008
(44790047)
26
78
3.40
7.43
1.5
1.6
—
—
—
0
0
(44790049)
26
78
3.40
7.43
1.5
1.6
—
—
—
0
0
(44790048)
26
78
3.40
7.43
1.5
1.6
—
—
—
0
0
(44806118)
26
78
3.40
7.43
1.5
1.6
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
12
9
13.49
7.40
1.2
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
19
46
4.20
7.30
1.2
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
19
46
4.20
7.30
1.2
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
19
46
4.20
7.30
1.2
1.1
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
11
7
15.88
7.24
1.2
1.1
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
102
582
1.85
7.23
5.3
3.9
ng/l
103.2
86.6
0.88
91
512
(3009508) Creatinine [Moles/volume] in Urine
310
2343
1.50
7.19
4.4
3.1
mmol/l
7.5
7.6
0.14
247
1962
(4306422)
28
90
3.18
7.19
1.3
1.2
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
309
2338
1.49
7.11
5.0
3.9
mg/mmol
20.8
9.0
1.82
195
1470
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
19
47
4.11
7.10
1.2
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
19
47
4.11
7.10
1.2
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
19
47
4.11
7.10
1.2
1.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
33
118
2.87
7.07
1.3
1.2
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
41
165
2.56
7.02
1.6
1.4
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
24
71
3.45
7.01
7.5
2.9
%
56.7
55.2
0.07
12
53
(3019550) Sodium [Moles/volume] in Serum or Plasma
810
7498
1.89
6.98
31.4
16.5
mmol/l
139.3
139.7
4.06
796
7307
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
754
6842
1.67
6.95
30.0
13.1
ml/min/173m2
79.5
79.8
0.10
671
5615
(3025941) Bacteria identified in Stool by Culture
75
392
2.00
6.90
1.3
1.2
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
811
7518
1.89
6.84
33.5
16.6
mmol/l
4.0
4.0
0.02
795
7311
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
18
44
4.15
6.84
1.9
1.6
u/l
3.1
11.4
1.15
13
25
(3051651) Icteric interference index of Serum or Plasma
19
49
3.94
6.73
4.8
3.3
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
14
28
5.06
6.72
4.0
2.8
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
293
2216
1.48
6.67
4.3
3.2
mg/l
468.9
248.3
0.39
193
1415
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
63
313
2.09
6.65
2.1
2.1
u/l
37.1
38.2
0.17
54
278
(3024980) IgG subclass 4 [Mass/volume] in Serum
30
106
2.89
6.58
1.7
1.8
g/l
0.8
0.9
0.03
24
79
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
741
6720
1.61
6.56
6.9
5.9
mmol/mol
39.9
40.0
0.08
689
6219
(3014576) Chloride [Moles/volume] in Serum or Plasma
145
943
1.64
6.47
11.9
6.8
mmol/l
104.3
104.1
0.12
145
915
(3011397) Hemoglobin [Presence] in Urine by Test strip
228
1648
1.52
6.44
3.0
3.7
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
42
179
2.41
6.39
1.4
1.2
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
49
224
2.26
6.37
1.5
1.6
iu/ml
0.0
0.1
0.44
17
41
(3051611) Lipemic interference index of Serum or Plasma
23
71
3.30
6.31
4.9
3.2
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
12
22
5.52
6.30
1.1
2.7
—
88552.6
—
0
5
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
287
2182
1.47
6.29
3.8
3.0
ng/l
2311.1
1308.8
1.85
235
1860
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
25
83
3.07
6.11
1.4
1.2
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
626
5509
1.46
6.08
4.5
3.9
pmol/l
14.8
14.8
0.20
557
4989
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
40
171
2.40
6.06
1.8
1.6
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
22
68
3.29
6.03
1.8
1.3
—
—
—
0
0
(4062490)
21
63
3.39
6.03
1.3
1.3
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
17
44
3.92
6.01
1.6
2.2
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
25
84
3.03
5.99
1.7
1.6
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
39
166
2.41
5.97
5.6
2.9
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
42
185
2.33
5.96
1.2
1.2
—
15.0
—
0
11
(3022145) Colonoscopy Study observation
127
815
1.65
5.96
1.5
1.3
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
9
6
15.13
5.91
1.0
1.0
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
821
7694
1.87
5.90
21.6
10.4
u/l
27.0
26.3
0.66
797
7416
(40767503) Oxygen content in Capillary blood by calculation
36
149
2.48
5.85
4.8
2.4
%
16.1
16.4
0.09
21
80
(3023183) Ammonium ion [Moles/volume] in Plasma
39
168
2.38
5.82
7.4
2.5
umol/l
40.1
35.5
0.46
34
140
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
39
169
2.37
5.75
1.8
1.6
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
20
61
3.33
5.61
1.4
1.3
g/l
3.1
2.6
0.30
15
39
(3024139) IgG subclass 3 [Mass/volume] in Serum
20
61
3.33
5.61
1.4
1.3
g/l
0.3
0.4
0.11
15
39
(3027135) IgG subclass 1 [Mass/volume] in Serum
20
61
3.33
5.61
1.4
1.3
g/l
10.6
7.6
0.53
15
40
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
25
90
2.83
5.34
1.4
1.2
nmol/l
0.7
0.6
0.31
25
85
(3017732) Neutrophils [#/volume] in Blood
81
478
1.76
5.16
4.4
3.1
e9/l
4.5
4.1
0.62
62
361
(3002256) Pathology report gross observation
137
927
1.56
5.15
1.4
1.3
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
29
116
2.55
5.08
1.3
1.3
mmol/l
50.5
62.8
0.83
24
102
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
9
9
10.09
5.03
1.1
1.0
%
103.2
112.4
—
9
9
(3044290) Cell count panel - Cerebral spinal fluid
31
129
2.45
5.01
1.6
1.2
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
23
82
2.85
5.01
6.9
3.6
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
23
82
2.85
5.01
1.5
1.4
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
291
2295
1.40
5.00
3.1
2.5
u/l
53.8
56.6
0.79
268
2135
(3023323) Follitropin [Units/volume] in Serum or Plasma
49
249
2.02
4.93
1.6
1.4
iu/l
21.2
27.5
0.90
39
214
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
22
78
2.87
4.84
1.3
1.3
nmol/l
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
14
37
3.83
4.82
1.2
1.1
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
8
7
11.52
4.79
1.0
2.1
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
38
177
2.20
4.78
1.7
1.3
u/l
8.0
9.6
0.34
24
146
(3026008) Bacteria identified in Urine by Culture
279
2200
1.39
4.76
3.7
3.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
39
184
2.17
4.76
1.2
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
39
185
2.16
4.70
1.4
1.3
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
69
403
1.77
4.57
3.0
3.2
pmol/l
4.3
4.5
0.72
61
351
(3016018) Differential panel - Cerebral spinal fluid
18
60
3.04
4.41
1.3
1.1
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
123
846
1.53
4.29
2.6
2.2
ug/g
122.3
120.8
0.02
101
669
(3022217) INR in Platelet poor plasma by Coagulation assay
136
956
1.50
4.28
31.2
24.9
inr
1.6
1.3
—
9
124
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
13
36
3.65
4.21
1.1
1.1
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
21
79
2.70
4.18
2.5
4.1
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
11
27
4.11
4.17
1.9
2.6
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
43
224
1.97
4.08
2.4
1.7
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
23
92
2.54
4.07
1.3
1.3
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
17
58
2.97
4.02
1.3
1.2
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
46
247
1.91
4.00
2.3
3.0
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
125
878
1.49
3.95
1.6
1.4
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
18
65
2.81
3.87
1.2
1.0
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
202
1561
1.38
3.79
1.4
1.2
u/ml
2.3
1.7
0.18
41
423
(40768443) Skin Pathology biopsy report
55
319
1.77
3.77
1.4
1.2
—
—
—
0
0
(3004451) EKG impression Narrative
13
39
3.37
3.77
1.3
1.3
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
200
1549
1.38
3.70
1.7
1.7
pmol/l
37908983.5
37470972.4
0.00
153
1273
(3015235) Bicarbonate [Moles/volume] in Capillary blood
38
197
1.97
3.68
4.1
2.6
mmol/l
24.6
24.7
0.02
38
173
(3017704) Immunofixation for Urine
13
40
3.28
3.63
1.6
1.8
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
9
17
5.34
3.51
1.9
1.7
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
87
580
1.55
3.51
4.2
2.9
kpa
4.6
4.5
0.13
80
561
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
12
36
3.37
3.48
1.2
1.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
235
1889
1.33
3.38
1.5
1.4
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
11
32
3.47
3.34
1.2
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
11
32
3.47
3.34
1.2
1.0
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
61
944
0.62
3.27
4.8
4.5
%
29.1
32.1
1.65
47
627
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
20
84
2.41
3.24
1.2
1.1
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
792
7532
1.47
3.21
24.0
13.4
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
14
49
2.89
3.20
1.7
1.4
u/l
11.1
14.2
0.90
14
44
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
23
104
2.24
3.18
1.6
1.5
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
39
216
1.84
3.14
1.5
1.2
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
32
166
1.96
3.13
3.2
2.2
g/l
136.1
131.9
0.30
23
124
(3023199) Leukocytes [#/volume] in Pleural fluid
21
92
2.31
3.12
1.3
1.3
e6/l
985.1
1615.3
0.84
16
62
(3034426) Prothrombin time (PT)
9
20
4.53
3.12
1.1
1.3
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
9
20
4.53
3.12
1.7
1.6
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
9
20
4.53
3.12
5.4
4.2
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
9
20
4.53
3.12
1.6
1.4
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
18
74
2.46
3.06
1.4
1.3
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
6
8
7.54
3.06
1.2
1.0
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
321
2727
1.28
3.01
4.1
3.9
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
772
7325
1.41
3.00
6.0
5.0
mmol/l
2.6
2.7
5.83
731
6717
(3032352) Blasts [#/volume] in Cerebral spinal fluid
5
5
10.05
2.98
2.2
5.8
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
755
7140
1.38
2.97
5.4
4.4
mmol/l
1.3
1.5
24.60
717
6540
(3029937) Albumin [Presence] in Urine by Test strip
232
1894
1.30
2.95
4.3
4.0
estimate
0.0
0.0
0.69
123
631
(3028679) Herpes simplex virus Ab [Presence] in Serum
10
30
3.36
2.91
1.1
1.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
731
6885
1.35
2.90
4.8
4.0
mmol/l
1.4
1.3
5.18
692
6269
(3005322) IgE [Units/volume] in Serum or Plasma
66
433
1.57
2.89
1.5
1.2
u/ml
204.6
237.4
0.14
57
393
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
160
1243
1.35
2.87
1.3
1.3
iu/ml
40.3
33.3
0.15
49
392
(40757373) Influenza virus identified in Isolate
7
13
5.42
2.87
1.3
1.6
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
6
9
6.70
2.87
1.3
1.0
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
17
71
2.42
2.81
2.2
1.4
—
—
—
0
0
(40768441) Liver Pathology biopsy report
15
59
2.57
2.79
2.9
1.3
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
19
84
2.29
2.78
1.4
1.3
e6/l
228949.0
40853.3
0.63
13
45
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
65
429
1.56
2.78
1.7
1.4
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
5
6
8.37
2.75
1.2
1.0
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
5
6
8.37
2.75
1.2
1.0
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
476
4267
1.25
2.74
3.2
2.8
—
—
—
0
0
(3000492) Spirometry study
93
664
1.45
2.74
1.7
1.4
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
42
249
1.72
2.73
1.5
1.6
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
28
146
1.95
2.73
1.4
1.2
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
16
66
2.45
2.72
1.3
1.8
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
747
7079
1.34
2.68
5.1
4.6
mmol/l
6.0
6.0
0.30
679
6437
(3017446) Testosterone [Moles/volume] in Serum or Plasma
75
518
1.49
2.62
3.4
2.2
nmol/l
12.7
13.1
0.15
70
458
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
38
222
1.74
2.61
1.6
2.2
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
17
74
2.32
2.59
1.0
1.1
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
25
128
1.98
2.57
1.9
1.7
—
—
—
0
0
(3011897) Casein IgE Ab [Units/volume] in Serum
5
7
7.18
2.55
1.2
1.0
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
6
11
5.48
2.54
4.2
6.0
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
38
224
1.73
2.54
1.4
1.5
ug/g
264.9
289.6
0.28
21
133
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
110
821
1.39
2.54
1.9
1.8
%
1.7
1.5
1.30
90
718
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
755
7184
1.34
2.49
5.6
4.5
mmol/l
4.3
4.6
13.81
723
6623
(44816559) Phosphatidylethanol [Mass/volume] in Blood
27
144
1.90
2.48
1.4
1.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
76
534
1.46
2.45
1.2
1.2
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
25
131
1.93
2.42
3.3
3.0
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
16
70
2.31
2.42
1.0
1.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
25
132
1.92
2.38
1.5
1.5
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
8
22
3.66
2.36
1.9
2.1
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
13
52
2.52
2.36
2.6
1.6
g/l
0.9
1.0
0.42
13
52
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
12
46
2.63
2.36
1.6
2.4
—
—
—
0
0
(40761535) Cells panel - Urine sediment
38
605
0.61
2.33
2.8
3.4
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
10
35
2.88
2.31
1.2
1.1
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
7
18
3.91
2.25
1.1
1.1
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
15
66
2.29
2.25
1.2
1.0
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
69
486
1.46
2.22
2.3
2.5
—
16.8
—
0
21
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
11
42
2.64
2.19
1.6
1.3
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
23
123
1.89
2.13
1.2
1.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
142
1133
1.30
2.12
1.6
1.5
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
18
88
2.07
2.12
1.4
1.6
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
25
138
1.84
2.11
4.4
2.5
—
—
—
0
0
(4211845)
9
31
2.92
2.07
3.6
3.0
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
9
31
2.92
2.07
1.0
1.1
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
5
10
5.02
2.07
1.0
1.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
82
605
1.39
2.06
3.3
2.7
ml/min/173m2
59.3
65.7
0.83
52
252
(3019230) Fractional oxyhemoglobin in Venous blood
24
132
1.84
2.05
7.7
2.0
%
62.2
60.5
0.13
24
132
(3013247) Albumin in CSF/Albumin in Serum or Plasma
5
11
4.56
1.94
1.0
1.0
mg/g
7.2
6.8
—
5
11
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
5
11
4.56
1.94
1.0
1.0
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
8
27
2.98
1.94
3.3
4.2
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
6
16
3.77
1.93
1.3
1.3
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
6
16
3.77
1.93
2.0
1.4
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
14
65
2.17
1.88
1.0
1.1
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
16
79
2.04
1.86
2.1
1.8
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
6
17
3.55
1.84
2.0
1.8
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
5
12
4.18
1.82
1.2
1.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
101
788
1.32
1.79
3.1
4.1
ug/l
3.7
24.5
1.28
83
649
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
8
29
2.77
1.79
1.1
1.2
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
825
8023
1.39
1.79
47.1
20.8
e9/l
315.2
248.1
27.82
808
7819
(3024731) MCV [Entitic volume]
825
8023
1.39
1.79
46.9
20.8
fl
92.1
91.1
3.41
816
7902
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
318
2824
1.20
1.78
4.5
3.6
ng/l
35.9
50.4
0.55
231
2006
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
143
1169
1.27
1.78
1.3
1.3
u/ml
23.3
12.3
0.52
39
443
(3035941) MCH [Entitic mass]
825
8024
1.39
1.77
46.8
20.7
pg
30.4
30.3
0.11
816
7901
(3026361) Erythrocytes [#/volume] in Blood
825
8025
1.38
1.76
47.0
20.8
e12/l
4.5
4.5
0.52
807
7800
(3010813) Leukocytes [#/volume] in Blood
825
8027
1.38
1.74
47.1
20.9
e9/l
8.2
6.7
6.73
808
7795
(3000963) Hemoglobin [Mass/volume] in Blood
825
8027
1.38
1.74
47.4
21.0
g/l
132.5
135.3
3.66
816
7902
(3028433) Virus identified in Specimen by Culture
8
30
2.68
1.72
1.6
1.4
—
—
—
0
0
(3014891) Appearance of Pleural fluid
5
13
3.86
1.71
1.4
1.3
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
48
0.00
1.70
0.0
3.0
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
64
470
1.39
1.69
4.1
3.5
mmol/l
2.1
1.9
0.22
47
347
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
19
104
1.84
1.68
1.4
1.5
—
—
—
0
0
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
8
31
2.59
1.66
1.1
1.6
nmol/l
1.2
8.3
—
8
22
(3013512) EKG study
250
2185
1.20
1.66
3.7
3.9
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
28
173
1.64
1.65
4.6
2.8
kpa
8.1
8.1
0.01
28
157
(3014765) Yersinia sp identified in Stool by Organism specific culture
35
230
1.54
1.62
1.2
1.2
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
5
14
3.59
1.61
1.2
1.2
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
5
14
3.59
1.61
1.0
1.0
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
5
14
3.59
1.61
2.0
1.4
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
10
43
2.34
1.60
1.1
1.0
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
19
106
1.81
1.59
1.0
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
35
233
1.52
1.54
1.2
1.2
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
7
27
2.60
1.51
2.7
3.3
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
6
21
2.87
1.50
8.5
3.9
%
45.7
51.0
—
6
21
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
6
21
2.87
1.50
1.0
1.0
miu/ml
1398.7
1531.3
—
6
21
(3047007) Chlamydophila sp Ab [Presence] in Serum
18
101
1.80
1.49
1.3
1.2
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
8
167
0.47
1.48
2.0
3.8
mg/l
33.0
25.6
—
8
107
(3042631) Mycobacterium sp identified in Specimen
19
109
1.76
1.47
3.3
2.5
—
—
—
0
0
(3016750) Collection duration of Urine
10
45
2.24
1.46
2.3
2.2
min
481.2
485.8
—
5
30
(3045414) Leukocytes [Presence] in Urine
44
311
1.44
1.46
1.9
1.9
—
—
—
0
0
(3011648) Oxygen content in Venous blood
12
59
2.05
1.44
2.8
1.8
%
9.0
10.6
0.63
12
59
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
27
173
1.58
1.41
2.0
1.3
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
9
40
2.26
1.40
1.6
1.2
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
7
29
2.42
1.39
1.0
1.5
—
—
—
0
0
(4027681)
9
41
2.21
1.37
1.2
1.2
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
9
41
2.21
1.37
9.7
19.4
nmol/l
1045.9
1561.9
—
9
41
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
17
2.95
1.36
1.0
1.2
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
50
368
1.38
1.34
2.4
2.5
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
61
465
1.33
1.32
1.4
1.2
iu/ml
194.9
146.2
0.34
26
182
(3009343) pH of Capillary blood
64
492
1.32
1.31
4.5
3.5
ph
7.4
7.4
0.37
17
57
(3029075) Extractable nuclear Ab panel - Serum
6
24
2.51
1.30
1.0
1.0
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
17
99
1.73
1.28
1.2
1.1
u/ml
0.9
1.6
—
10
36
(3014051) Protein [Presence] in Urine by Test strip
25
162
1.56
1.27
2.1
2.3
—
—
—
0
0
(3019060) Gas panel - Arterial blood
64
496
1.31
1.25
3.6
5.6
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
25
2.41
1.24
1.8
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
33
229
1.46
1.23
1.2
1.2
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
41
297
1.40
1.22
3.5
3.3
u/ml
832.8
4654.1
0.57
36
256
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
13
71
1.84
1.20
2.3
1.8
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
38
2.12
1.18
1.0
1.1
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
5
20
2.51
1.15
1.2
1.3
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
46
344
1.36
1.15
1.1
1.1
—
163.3
—
0
8
(3022621) pH of Urine by Test strip
60
468
1.30
1.13
2.6
3.0
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
11
58
1.91
1.12
2.2
2.2
ml
712.0
614.3
—
5
37
(3004716) Salmonella sp identified in Stool by Organism specific culture
47
355
1.34
1.11
1.3
1.3
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
20
128
1.58
1.09
1.8
1.6
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
7
32
2.20
1.08
1.0
1.3
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
158
1379
1.18
1.07
2.8
3.0
ug/l
0.6
0.8
1.60
116
923
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
29
203
1.44
1.06
2.1
1.4
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
12
67
1.80
1.05
1.3
1.1
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
16
98
1.64
1.03
7.8
2.5
—
—
—
0
0
(3035880) pH of Pleural fluid
9
46
1.97
1.03
1.1
1.2
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
9
46
1.97
1.03
1.1
1.4
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
18
275
0.65
1.03
2.4
3.9
mmol/l
1.3
1.3
0.03
18
267
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
11
60
1.84
1.03
2.0
1.4
%
26.0
33.1
—
5
40
(3049717) Cytology report of Urine Cyto stain
40
300
1.35
1.00
3.8
2.7
—
—
—
0
0
(44806420)
5
23
2.18
0.98
2.0
2.4
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
21
140
1.51
0.98
1.7
2.1
u/l
8863.0
3440.6
—
7
50
(3019832) Treponema pallidum Ab [Presence] in Serum
62
497
1.27
0.98
1.9
1.6
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
12
199
0.60
0.98
2.3
4.9
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
16
100
1.61
0.97
1.2
1.1
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
18
116
1.56
0.97
1.5
1.3
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
21
141
1.50
0.95
10.7
2.9
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
9
51
1.77
0.94
2.0
1.3
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
9
51
1.77
0.94
2.0
1.3
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
14
85
1.66
0.94
1.1
1.1
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
8
146
0.54
0.93
1.0
1.2
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
12
70
1.72
0.93
1.4
2.2
—
—
—
0
0
(4281824)
12
70
1.72
0.93
1.2
1.1
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
15
232
0.64
0.92
2.7
3.9
mmol/l
3.8
3.9
0.33
15
211
(3033705) Calcium.ionized [Moles/volume] in Venous blood
5
104
0.48
0.89
1.6
2.6
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
6
30
2.01
0.87
1.2
1.1
mmol/l
6.2
6.8
—
6
30
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
11
64
1.73
0.86
1.4
1.2
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
11
64
1.73
0.86
1.5
1.2
nmol/l
376.6
378.6
0.01
11
54
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
47
590
0.79
0.86
1.7
1.7
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
14
88
1.60
0.84
2.1
1.6
%
62.4
59.8
—
7
62
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
16
238
0.67
0.84
2.6
1.7
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
13
201
0.64
0.82
1.2
1.4
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
6
32
1.88
0.82
2.0
1.7
ug/l
50.2
54.4
—
6
32
(3032773) Endomysium IgG Ab [Titer] in Serum
11
66
1.68
0.79
1.2
1.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
30
394
0.75
0.78
1.3
1.4
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
13
82
1.59
0.78
1.1
1.1
u/ml
0.1
2.3
—
7
18
(1761868) Lipid panel - Serum or Plasma
270
2501
1.11
0.77
3.5
2.9
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
7
38
1.85
0.73
1.0
1.0
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
5
25
2.01
0.72
1.0
1.1
iu/ml
108.2
180.6
—
5
25
(4094501)
26
194
1.35
0.72
1.1
1.1
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
144
1599
0.88
0.70
3.5
4.1
kg/l
1.0
1.0
0.01
31
214
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
26
195
1.34
0.70
3.4
2.4
ug/min
282.9
104.5
0.42
14
117
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
9
58
1.56
0.70
1.1
1.1
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
5
27
1.86
0.68
2.8
1.9
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
5
27
1.86
0.68
1.2
1.3
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
5
27
1.86
0.68
2.8
1.9
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
5
28
1.79
0.66
2.8
1.9
—
—
—
0
0
(3017315) Amylase [Enzymatic activity/volume] in Urine
7
44
1.60
0.65
1.0
1.1
u/l
353.4
553.2
—
7
38
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
17
120
1.42
0.65
1.9
1.5
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
53
446
1.20
0.60
1.4
1.2
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
22
166
1.33
0.59
1.8
1.8
iu/l
3.7
5.4
—
8
51
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
8
53
1.51
0.58
1.5
1.2
—
70.4
—
0
7
(4010399)
64
550
1.18
0.58
1.5
1.4
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
52
613
0.84
0.57
1.3
1.4
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
12
81
1.49
0.57
1.6
1.3
—
—
—
0
0
(3019225) pH of Specimen
63
728
0.86
0.56
3.8
4.0
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
9
62
1.46
0.53
1.9
1.5
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
6
40
1.50
0.51
1.2
1.2
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
18
136
1.33
0.49
1.6
1.5
—
—
—
0
0
(1002224) Polysomnography panel
36
300
1.21
0.47
1.1
1.1
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
7
49
1.43
0.46
1.4
1.4
—
33.3
—
0
6
(3020891) Body temperature
23
286
0.80
0.45
4.0
4.5
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
7
50
1.40
0.45
1.0
1.0
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
15
112
1.35
0.45
1.7
1.6
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
10
69
1.45
0.44
1.5
1.2
—
—
—
0
0
(3024263) Appearance of Synovial fluid
5
31
1.62
0.43
4.4
1.5
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
5
31
1.62
0.43
1.0
1.0
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
10
70
1.43
0.42
1.2
1.9
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
5
33
1.52
0.41
1.0
1.3
nmol/l
168.2
142.4
—
5
33
(3051101) Glucose [Moles/volume] in Cord blood
0
15
0.00
0.41
0.0
5.7
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
16
0.00
0.41
0.0
1.0
—
25.4
—
0
16
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.1
—
1.1
—
0
6
(3000285) Sodium [Moles/volume] in Blood
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
17
0.00
0.40
0.0
1.4
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
5
34
1.47
0.40
1.0
1.1
—
—
—
0
0
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
0
18
0.00
0.40
0.0
6.2
—
73.2
—
0
13
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
7
101
0.69
0.39
1.3
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
7
101
0.69
0.39
1.3
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
7
101
0.69
0.39
1.1
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
7
101
0.69
0.39
1.1
1.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
61
542
1.13
0.39
2.4
1.9
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
7
105
0.66
0.39
1.3
1.6
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
5
35
1.43
0.39
2.8
1.7
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
5
35
1.43
0.39
2.8
1.7
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
5
35
1.43
0.39
5.2
7.0
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
5
35
1.43
0.39
2.8
1.7
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
5
35
1.43
0.39
2.8
1.7
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
5
36
1.39
0.38
1.8
1.3
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
9
67
1.35
0.38
1.3
1.1
nmol/l
1.2
1.5
—
9
62
(3050129) First trimester maternal screen panel - Serum or Plasma
8
112
0.71
0.37
1.3
1.4
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
29
343
0.84
0.37
2.1
1.7
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
13
99
1.32
0.35
1.4
1.2
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
15
117
1.29
0.35
1.6
1.5
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
11
82
1.35
0.34
1.7
1.2
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
22
182
1.21
0.33
1.3
1.2
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
6
86
0.70
0.33
1.2
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
6
86
0.70
0.33
1.3
1.4
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
6
88
0.68
0.33
1.5
1.6
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
6
88
0.68
0.33
1.2
1.5
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
109
1013
1.09
0.33
1.5
1.4
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
6
47
1.28
0.32
2.7
2.5
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
66
601
1.11
0.30
2.4
2.0
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
13
104
1.25
0.26
1.7
1.5
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
11
138
0.79
0.25
1.6
1.7
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
33
371
0.89
0.25
2.5
3.8
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
12
96
1.25
0.24
1.2
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
12
97
1.24
0.23
1.2
1.1
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
5
39
1.28
0.23
1.4
1.2
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
5
39
1.28
0.23
1.4
1.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
20
172
1.17
0.22
1.3
1.3
—
—
—
0
0
(3042552) Rheumatoid factor [Units/volume] in Pleural fluid
0
11
0.00
0.21
0.0
1.0
—
9.0
—
0
5
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(44806071)
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
0
10
0.00
0.21
0.0
3.5
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
10
0.00
0.21
0.0
6.6
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
5
43
1.16
0.21
7.2
3.1
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
7
58
1.21
0.18
1.1
1.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
56
599
0.93
0.18
1.3
1.4
—
—
—
0
0
(3008898) HLA-B27 [Presence]
27
243
1.11
0.17
1.0
1.1
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
7
62
1.13
0.17
2.3
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
7
62
1.13
0.17
2.3
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
7
62
1.13
0.17
2.3
1.6
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
7
62
1.13
0.17
1.4
1.5
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
22
196
1.13
0.16
5.9
2.1
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
17
149
1.14
0.15
1.5
1.6
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
6
78
0.77
0.15
2.0
1.5
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
39
361
1.08
0.15
6.3
2.4
%
0.7
0.7
0.06
39
349
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
82
782
1.05
0.15
1.5
1.6
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
31
287
1.08
0.12
1.5
1.8
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
23
210
1.10
0.12
5.8
2.0
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
16
143
1.12
0.11
1.7
3.6
u/ml
484.8
314.4
0.13
16
138
(3027008) Opiates [Presence] in Urine
23
211
1.09
0.11
5.8
2.0
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
23
211
1.09
0.11
5.8
2.0
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
5
44
1.14
0.10
1.0
1.8
nmol/l
15.8
20.3
—
5
38
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
37
351
1.06
0.08
1.0
1.0
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
5
61
0.82
0.08
1.4
1.3
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
5
60
0.83
0.08
1.4
1.4
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
6
71
0.84
0.07
1.3
1.6
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
19
176
1.08
0.07
1.4
1.5
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
242
2391
1.02
0.06
4.2
5.0
ug/l
2.1
2.5
0.53
215
2134
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
28
292
0.96
0.04
2.8
1.8
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
27
259
1.04
0.04
2.4
3.1
g/l
0.5
0.2
0.66
18
110
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
26
271
0.96
0.04
2.5
1.7
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
10
109
0.92
0.04
2.1
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
10
109
0.92
0.04
2.1
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
10
108
0.93
0.03
2.1
1.3
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
13
122
1.07
0.02
1.3
1.5
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
63
641
0.98
0.02
2.2
2.4
ug/l
7.5
6.8
0.15
56
561
(1001926) Buprenorphine [Presence] in Urine by Screen method
17
162
1.05
0.02
7.3
1.9
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
21
202
1.04
0.02
1.2
1.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
10
107
0.93
0.02
2.1
1.3
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
10
107
0.93
0.02
2.1
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
10
107
0.93
0.02
2.1
1.3
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
40
408
0.98
0.01
3.2
2.7
e6/l
0.1
0.2
0.39
40
394
(4034850)
23
224
1.03
0.00
14.9
10.7
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
18
178
1.01
0.00
1.2
1.3
miu/ml
233.2
241.4
0.04
11
87
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
192
1922
1.00
0.00
3.5
4.3
%
24.5
21.3
1.57
82
923
(3022313) Gas panel - Capillary blood
36
359
1.00
0.00
4.5
3.5
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
22
221
1.00
0.00
1.5
1.7
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
21
209
1.00
0.00
4.9
1.8
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
11
109
1.01
0.00
3.0
2.6
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
6
61
0.98
0.00
1.0
1.1
—
—
—
0
0
(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
65.2
—
0
5
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
7
0.00
0.00
0.0
5.7
—
—
—
0
0
(3027653) Mycophenolate [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
6.6
—
2.0
—
0
5
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
6
0.00
0.00
0.0
3.3
—
—
—
0
0
(4146454)
8
82
0.98
0.00
3.4
2.8
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3044416) Complement C4 [Mass/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
0.1
—
0
5
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
9
0.00
0.00
0.0
1.0
—
17.4
—
0
9
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
9
90
1.00
0.00
1.2
1.2
mmol/l
7.5
7.3
—
9
59
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
8
0.00
0.00
0.0
2.5
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(4024509)
6
63
0.95
0.00
1.5
1.3
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
7
0.00
0.00
0.0
2.6
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013762) Body weight Measured
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
54
0.93
0.00
1.8
1.4
—
—
—
0
0
(3001729) Color of Synovial fluid
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint D3_BLOODNAS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| D3_BLOODNAS | 2.238 [1.91, 2.63] | < 0.001 |
| Birth year | 0.995 [0.99, 1.0] | 0.245 |
During the follow-up period (1.1.1998 — 31.12.2019), 570 out of 2131 females with D3_BLOODNAS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| D3_BLOODNAS | 2.256 [1.9, 2.67] | < 0.001 |
| Birth year | 0.981 [0.97, 0.99] | < 0.001 |
During the follow-up period (1.1.1998 — 31.12.2019), 665 out of 1883 males with D3_BLOODNAS died.
Mortality risk
Mortality risk for people of age
years, who have D3_BLOODNAS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.227% | 0.362% |
| 5 | 1.374% | 2.281% |
| 10 | 3.61% | 5.483% |
| 15 | 6.907% | 9.997% |
| 20 | 11.592% | 16.14% |
Relationships between endpoints
↥Index endpoint: D3_BLOODNAS – Other and unspecified diseases of blood and blood-forming organs
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data